🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2032

Annual patent cliff calendar for 2032 — US pharmaceutical patents by expiration date.

Patents
1,123

Quick answer

1,123 indexed pharmaceutical patents have expiration dates in 2032. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 8188289

    Conformationally restricted urea inhibitors of soluble epoxide hydrolase

    The Regents of the University of California · Granted Tue May 29 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8188294

    Process for preparing biphenyl imidazole compounds

    Theravance, Inc. · Granted Tue May 29 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8193306

    Methods for preparing polymeric reagents and compositions of polymeric reagents

    Nektar Therapeutics · Granted Tue Jun 05 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8192741

    Method of treating rheumatoid arthritis with an anti-IL-6R antibody

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Jun 05 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8193309

    Compositions and methods for preventing or treating cancer

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Jun 05 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8193352

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Tue Jun 05 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8193202

    LIMK2 inhibitors, compositions comprising them, and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted Tue Jun 05 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8192720

    Compositions and methods for detection, prevention, and treatment of anthrax and other infectious diseases

    BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE OF THE UNIVERSITY OF NEVADA, RENO · Granted Tue Jun 05 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8192991

    Methods of eliciting or boosting a cellular immune response

    The Regents of the University of California · Granted Tue Jun 05 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8193167

    Pharmacologically active agents containing esterified phosphonates and methods for use thereof

    The United States of America—Department of Veterans Affairs · Granted Tue Jun 05 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8193181

    Xinafoate salt of N4-(2,2-difluoro-4H-benzo[1,4]oxazin-3-one)-6-yl]-5-fluoro-N2-[3-(methylaminocarbonylmethyleneoxy) phenyl]2,4-pyrimidinediamine

    Rigel Pharmaceuticals, Inc. · Granted Tue Jun 05 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8193197

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Tue Jun 05 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8193225

    Isoxazole amides, derivatives and methods of chemical induction of neurogenesis

    The Board of Regents of the University of Texas System · Granted Tue Jun 05 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8193204

    Solid forms of (S)-ethyl 2-amino-3-(4-(2-amino-6-((R)-1- (4-chloro-2-(3-methyl-1H-pyrazol-1-YL)phenyl)2,2,2-trifluoroethoxy)-pyrimidin-4-YL)phenyl)propanoate and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted Tue Jun 05 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8193211

    Controlled release compositions of gamma-hydroxybutyrate

    Supernus Pharmaceuticals, Inc. · Granted Tue Jun 05 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8193152

    Treatment or prevention of hemorrhagic viral infections with immunomodulator compounds

    The Board of Regents of the University of Texas System · Granted Tue Jun 05 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8193151

    Methods for treating atrial or ventricular arrhythmias

    Northwestern University · Granted Tue Jun 05 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8193312

    Bone morphogenic protein binding peptide

    The Regents of the University of California · Granted Tue Jun 05 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8193330

    Polynucleotides comprising Neurogenin3 promoter and bHLH encoding domains

    The Regents of the University of California · Granted Tue Jun 05 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8193339

    Synthesis of β-nucleosides

    PHARMAESSENTIA CORPORATION · Granted Tue Jun 05 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8193357

    Androgen receptor modulator compounds

    Ligand Pharmaceuticals Incorporated · Granted Tue Jun 05 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8193194

    Ion channel modulators and methods of use

    Vertex Pharmaceuticals Incorporated · Granted Tue Jun 05 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8193145

    Laminins, derivatives, and compositions including same and methods for their therapeutic use

    BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE OF THE UNIVERSITY OF NEVADA, RENO · Granted Tue Jun 05 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 31 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8198242

    Variants of C-type natriuretic peptide

    BIOMARIN PHARMACEUTICAL INC. · Granted Tue Jun 12 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8198304

    Guanidine-containing compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Tue Jun 12 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8197823

    Vaccine for porcine reproductive and respiratory syndrome, a preparion method and use thereof

    China Animal Disease Control Center · Granted Tue Jun 12 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8197818

    EML4-ALK fusion gene

    CUREGENE K.K. · Granted Tue Jun 12 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8197870

    Depolymerization extraction of compounds from birch bark

    Regents of the University of Minnesota · Granted Tue Jun 12 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8198254

    Annexin A9 (ANXA9) biomarker and therapeutic target in epithelial cancer

    The Regents of the University of California · Granted Tue Jun 12 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8198255

    SiRNA-mediated inhibition of doublecortin and Ca2+/calmodulin-dependent kinase-like-1

    The Board of Regents of the University of Oklahoma · Granted Tue Jun 12 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8198402

    Smoothened polypeptides and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 12 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8197838

    Sustained release systems of ascorbic acid phosphate

    Advanced Technologies and Regenerative Medicine, LLC · Granted Tue Jun 12 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8198244

    Regulation of skin characteristics by DICKKOPF1 (DKK1)

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jun 12 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8198042

    CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infection

    THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 12 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8198406

    Methods and compositions for inhibiting angiogenesis

    Northwestern University · Granted Tue Jun 12 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8198469

    Crystalline forms of tigecycline and processes for preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 12 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8198470

    Crystalline form II of tigecycline and processes for preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 12 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8198322

    Apoptotic and anti-tumor activities of metallo-salens

    The Board of Regents of the University of Texas System · Granted Tue Jun 12 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8202538

    Orally disintegrating layered compositions

    Capricorn Pharma Inc. · Granted Tue Jun 19 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8202844

    Indole antiviral compositions and methods

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jun 19 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8202517

    Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof

    HALOZYME, INC. · Granted Tue Jun 19 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8202861

    Compositions useful as inhibitors of voltage-gated sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Tue Jun 19 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8202520

    Method of immunizing humans against Salmonella typhi using a Vi-rEPA conjugate vaccine

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 19 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8202549

    Mesocellular oxide foams as hemostatic compositions and methods of use

    The Regents of the University of California · Granted Tue Jun 19 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8202889

    Inhibitors of bacterial IMPDH

    Vertex Pharmaceuticals Incorporated · Granted Tue Jun 19 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8202980

    Method and medicament for inhibiting the expression of a given gene

    Alnylam Pharmaceuticals, Inc. · Granted Tue Jun 19 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8202902

    Bivalent SMAC mimetics and the uses thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jun 19 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8203030

    Transgenic mouse models for diseases caused by mtDNA mutations and related methods

    The Regents of the University of California · Granted Tue Jun 19 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2032?

1,123 published patents in our USPTO index have expiration dates falling in calendar year 2032.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.